PHARMACY

Armas debuts generic Vidaza
Armas Pharmaceuticals is introducing generic Vidaza, which had a market value of about $116 million, the company said.
Central fill’s patient care proposition
With patient care in focus when it comes to reimbursement, Innovation executives said they have seen chain pharmacies shift their investments to central-fill automation.

Indivior gets FDA nod for Perseris

Indivior’s once-monthly Perseris now offers a new option for treating adults with schizophrenia.
Hikma unveils generic Halcion

Hikma is introducing generic Halcion, which had a market value of about $27 million for the year ended September 2018, according to IQVIA data.
FamilyWize updates prescription discount mobile app

FamilyWize said its enhanced mobile app optimizes the user experience with customizable features to find the lowest cost prescription prices.
Pharmacist-administered immunization opportunities are expanding

The National Community Pharmacist Association’s John Beckner writes that pharmacists can continue to play a pivotal role in administering immunizations and improving patient health
Nexus gets FDA nod for generic Trisenox

Nexus is offering a generic version of Teva's Trisenox for intravenous use in leukemia patients.
FDA clears new indication for Adcetris

Seattle Genetics' Adcetris injection (brentuximab vedotin) has received the FDA's nod to be used in combination with chemotherapy for adult patients with certain types of peripheral T-cell lymphoma.
Glenmark gets FDA's blessing for generic Aubagio

Glenmark Pharmaceuticals has received the FDA's OK for generic Aubagio, which had a market value of about $1.6 billion for the year ended September 2018, according to IQVIA.
Former senator joins Blink Health’s board

Former Sen. Kelly Ayotte will take an active role supporting Blink Health's mission of bringing transparency and affordability to the prescription drug industry.